Sarepta Therapeutics, which won a pioneering Food and Drug Administration approval for its Duchenne muscular dystrophy drug last year, has settled a patent dispute with rival BioMarin over the «exon - skipping» technology at heart of the companies» muscular dystrophy treatments. (fortune.com)
We'd be sabotaging the vision at the very heart of this company.» (health.com)
There had also been OSCA V - 12 engines, unsuccessful Formula 1 cars, a winning 750 - cc sports racer, a lovely 2.0 - liter in - line six, even a Fiat 1100 - based Formula Junior, but the true heart of the company and the source of its ultimate reputation was the MT4. (automobilemag.com)